CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 331 enrolled
Drug / intervention
DF289 +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01395966
NCT01395966Phase 3Completed

Clinical Study to Assess the Efficacy and Safety of DF289 Plus DF277 Otic Solution in the Treatment of Middle Ear Infections in Pediatric Patients

Salvat·interventional·Posted Jul 18, 2011·Updated Oct 22, 2015

In Brief

A Phase 3 clinical trial evaluating DF289, DF277, and 1 other intervention for Acute Otitis Media. Completed, enrolled 331 participants across 1 site.

Detailed Summary

The purpose of this study is to determine if the combination of DF289 plus DF277 is safe and effective in treating middle ear infections in children with ear tubes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesSpain
Collaborators--

Timeline

Phase 3CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJul 18, 2011
Enrollment StartJun 1, 2011
Primary CompletionJun 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 15.0 years ago

Interventions

DF289drug

Ear drops

DF277drug

Ear drops

DF289 plus DF277drug

Ear drops